Torrent Pharmaceuticals Limited

Price Chart

Risk-Adjusted Performance

Torrent Pharmaceuticals Limited (TORNTPHARM) Price Performance

Torrent Pharmaceuticals Limited (TORNTPHARM) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR4179.50, up 0.57% from the previous close.

Over the past year, TORNTPHARM has traded between a low of INR3514.70 and a high of INR4446.00. The stock has gained 16.2% over this period. It is currently 6.0% below its 52-week high.

Torrent Pharmaceuticals Limited has a market capitalization of $1.41T, with a price-to-earnings ratio of 62.07 and a dividend yield of 0.84%.

About Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Compare Torrent Pharmaceuticals Limited

Side-by-side comparison against top Healthcare peers.